Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Maillard

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
BMC Nephrology|June 3, 2010
MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?Pierre Delanaye, Etienne Cavalier, Christophe Mariat, et al.
Pediatric Nephrology (Berlin, Germany)|November 20, 2025
IgA nephropathy new therapies: from data in adults to application in childrenAlexandra Cambier, Lison Lachize Neanne, Srishti Sahu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2008
Creatinine calibration in NHANES: is a revised MDRD study formula needed?Pierre Delanaye, Etienne Cavalier, Nicolas Maillard, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2010
Creatinine-based GFR predicting equations in renal transplantation: reassessing the tubular secretion effectNicolas Maillard, Manolie Mehdi, Lise Thibaudin, et al.
Blood Purification|August 18, 2015
Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA AntibodiesNicolas Maillard, Lena Absi, Guillaume Claisse, et al.
Clinical Kidney Journal|March 28, 2015
Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unitGuillaume Claisse, Xavier Delavenne, Ingrid Masson, et al.
Human Immunology|February 13, 2017
Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodiesGuillaume Claisse, Lena Absi, Fabrice Cognasse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2023
Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathyGabriel Ștefan, Perrine Jullien, Ingrid Masson, et al.
Advances in Therapy|November 12, 2025
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-analysis and Discussion of Appropriate MethodologyNicolas Maillard, Khalil El Karoui, Alex Mercer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 31, 2007
Estimated glomerular filtration rate as an end point in kidney transplant trial: where do we stand?Christophe Mariat, Nicolas Maillard, Manolie Phayphet, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
BMC Nephrology|June 3, 2010
MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?Pierre Delanaye, Etienne Cavalier, Christophe Mariat, et al.
Pediatric Nephrology (Berlin, Germany)|November 20, 2025
IgA nephropathy new therapies: from data in adults to application in childrenAlexandra Cambier, Lison Lachize Neanne, Srishti Sahu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2008
Creatinine calibration in NHANES: is a revised MDRD study formula needed?Pierre Delanaye, Etienne Cavalier, Nicolas Maillard, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2010
Creatinine-based GFR predicting equations in renal transplantation: reassessing the tubular secretion effectNicolas Maillard, Manolie Mehdi, Lise Thibaudin, et al.
Blood Purification|August 18, 2015
Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA AntibodiesNicolas Maillard, Lena Absi, Guillaume Claisse, et al.
Clinical Kidney Journal|March 28, 2015
Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unitGuillaume Claisse, Xavier Delavenne, Ingrid Masson, et al.
Human Immunology|February 13, 2017
Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodiesGuillaume Claisse, Lena Absi, Fabrice Cognasse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2023
Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathyGabriel Ștefan, Perrine Jullien, Ingrid Masson, et al.
Advances in Therapy|November 12, 2025
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-analysis and Discussion of Appropriate MethodologyNicolas Maillard, Khalil El Karoui, Alex Mercer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 31, 2007
Estimated glomerular filtration rate as an end point in kidney transplant trial: where do we stand?Christophe Mariat, Nicolas Maillard, Manolie Phayphet, et al.
Pageof 9